BiotechTube

Eravacycline 2mg/kg + Eravacycline 1.5mg/kg

Phase 2Recruiting
0 watching 0 views this week⚡ Active
47
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Complicated Intra-abdominal Infections (cIAI)

Conditions

Complicated Intra-abdominal Infections (cIAI)

Trial Timeline

May 22, 2025 → Mar 19, 2029

NCT ID
NCT06794541

About Eravacycline 2mg/kg + Eravacycline 1.5mg/kg

Eravacycline 2mg/kg + Eravacycline 1.5mg/kg is a phase 2 stage product being developed by Innoviva for Complicated Intra-abdominal Infections (cIAI). The current trial status is recruiting. This product is registered under clinical trial identifier NCT06794541. Target conditions include Complicated Intra-abdominal Infections (cIAI).

Hype Score Breakdown

Clinical
17
Activity
12
Company
5
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT06794541Phase 2Recruiting

Competing Products

20 competing products in Complicated Intra-abdominal Infections (cIAI)

See all competitors
ProductCompanyStageHype Score
ZY19489 + Ferroquine (FQ) + PlaceboZydus LifesciencesPhase 1
33
HRS-8427 + Imipenem and Cilastatin Sodium + HRS-8427 placebo + Imipenem and Cilastatin Sodium placeboJiangsu Hengrui MedicinePhase 3
77
HRS -8427 + Imipenem and Cilastatin SodiumJiangsu Hengrui MedicinePhase 2
52
Ceftolozane/Tazobactam + Metronidazole + Meropenem + PlaceboMerckPhase 3
77
Vancomycin + Daptomycin + Semi-Synthetic PenicillinMerckApproved
85
CXA-201 and metronidazole + MeropenemMerckPhase 3
77
CXA-101 + CeftazidimeMerckPhase 2
52
Ceftolozane/Tazobactam + MeropenemMerckPhase 2
52
Imipenem+Cilastatin/RelebactamMerckPhase 3
77
Daptomycin + VancomycinMerckApproved
85
CXA-101/ tazobactam and metronidazole + meropenem plus saline placeboMerckPhase 2
52
CXA-201 + LevofloxacinMerckPhase 3
77
Ceftolozane/Tazobactam + Metronidazole + Meropenem + Placebo for MetronidazoleMerckPhase 2
52
MK0826; ertapenem sodium + Comparator: ceftriaxone + metronidazoleMerckApproved
85
MK0826, /Duration of Treatment : 8 Weeks + Comparator : piperacillin sodium (+) tazobactam sodium /Duration of Treatment : 8 WeeksMerckPhase 3
77
KLU156 + CoartemNovartisPhase 3
77
LYS228 + Standard of care therapyNovartisPhase 2
52
Artemether-lumefantrine (COA566)NovartisPhase 2/3
65
INE963NovartisPhase 2
52
KAE609 + SoC (Coartem) + KLU156NovartisPhase 2
52

Other Products from Innoviva

Angiotensin-IIApproved
80
Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours) + Ceftriaxone for Injection + Amoxicillin + Azithromcyin + clarithromycin + Clofazimine + Ethambutol + Amikacin Injection + tigecycline + Imipenem + Cilastatin + Cefoxitin + Amikacin (Inhalation) + linezolid + Trimethoprim / Sulfamethoxazole + Doxycycline + moxifloxacin + bedaquiline + RifabutinPhase 2
47
Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours) + Sulbactam 20mg/kg-Durlobactam 20mg/kg (Every 8 hours) + Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 8 hours) + Sulbactam 20mg/kg-Durlobactam 20mg/kg (Every 12 hours)Phase 1
28